Constitutively activated ERK sensitizes cancer cells to doxorubicin: Involvement of p53-EGFR-ERK pathway
Crossref DOI link: https://doi.org/10.1007/s12038-017-9667-8
Published Online: 2017-02-03
Published Print: 2017-03
Update policy: https://doi.org/10.1007/springer_crossmark_policy
Kumari, Ratna
Chouhan, Surbhi
Singh, Snahlata
Chhipa, Rishi Raj
Ajay, Amrendra Kumar
Bhat, Manoj Kumar
License valid from 2017-02-03